January 2011 , 5:O11 ,
Open Access This content is freely available online to anyone, anywhere at any time.
Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) significantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: results of the CAMELIA clinical trial
Within this Article
- Methods
- 作者单位：Fran?ois-Xavier Blanc (1)
Thim Sok (2)
Didier Laureillard (2) (3)
Laurence Borand (4)
Claire Rekacewicz (5)
Eric Nerrienet (4)
Yoann Madec (6)
Olivier Marcy (2)
Sarin Chan (2)
Narom Prak (7)
Chindamony Kim (8) (9)
Khemarin Kim Lak (10) (2)
Chanroeurn Hak (11)
Bunnet Dim (12) (2) (9)
Chhun Im Sin (13)
Sath Sun (10) (2)
Bertrand Guillard (4)
Borann Sar (4)
Sirenda Vong (4)
Marcelo Fernandez (2)
Lawrence Fox (14)
Jean-Fran?ois Delfraissy (5)
Anne E Goldfeld (15) (2)
1. Pneumology Unit, Internal Medicine Department, Bicêtre Hospital, Assistance Publique-H?pitaux de Paris, Le Kremlin-Bicêtre, France
2. Cambodian Health Committee, Phnom Penh, Cambodia
3. European Georges Pompidou Hospital, Assistance Publique-H?pitaux de Paris, Paris, France
4. Institut Pasteur in Cambodia, Phnom Penh, Cambodia
5. Agence Nationale de Recherche sur le SIDA et les hépatites virales (ANRS), Paris, France
6. Institut Pasteur, Paris, France
7. Infectious Disease Department, Khmer Soviet Friendship Hospital, Phnom Penh, Cambodia
8. Donkeo Provincial Hospital, Takeo, Cambodia
9. Médecins Sans Frontières, Phnom Penh, Cambodia
10. Svay Rieng Provincial Hospital, Svay Rieng, Cambodia
11. Calmette Hospital, Phnom Penh, Cambodia
12. Siem Reap Provincial Hospital, Siem Reap, Cambodia
13. Pneumology Department, Khmer Soviet Friendship Hospital, Phnom Penh, Cambodia
14. Division of AIDS, NIAID, National Institute of Health, Bethesda, USA
15. Immune Disease Institute, Harvard Medical School, Boston, USA
Results
Conclusion
文摘